A systematic review of second-line controller combination therapy options for the management of asthma-Reference-Cited by-同舟云学术

A systematic review of second-line controller combination therapy options for the management of asthma

Published:2018-12-08 Issue:2 Volume:35 Page:77-85
ISSN:1172-0360
Container-title:Drugs & Therapy Perspectives
language:en
Short-container-title:Drugs Ther Perspect

Author:

Rajanandh Muhasaparur Ganesan,Ahalya Sivaguru Paramesh,Anjali Rajendran,Abirami Arunagiri,Bhuvaneswari Jamindar Ganesh

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/article/10.1007/s40267-018-0591-2/fulltext.html

Reference26 articles.

1. Rajanandh MG. An overview and update on asthma and its management. J Med Sci. 2015;15:122–9.

2. Ducharme FM. Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence. BMJ. 2003;326(7390):621.

3. Rajanandh MG, Nageswari AD, Irshad PP, et al. Dose-reduction of inhaled corticosteroids with the addition of leukotriene antagonist is clinical significance in asthma patients? A randomized clinical trial. World Appl Sci J. 2013;24:276–81.

4. Ilango K, Rajanaandh MG, Nageswari AD. Roflumilast, an upcoming drug for curing asthma and COPD. Int J Pharm Res Tech. 2013;5:130–5.

5. Virchow JC, Prasse JR, Naya A, et al. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med. 2000;162:578–85.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of L-Carnosine in children with autism spectrum disorders: a systematic review and meta-analysis of randomised controlled trials;Amino Acids;2021-03-11